CLINICAL_TRIALS
withdrawal
· 2016-10-28
Clinical Trial Update: Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury [Phase 4]
Summary
A Phase 4 clinical trial evaluating the single-dose pharmacokinetics of intravenous daptomycin in patients with burn injuries has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Zurich | Conditions: Burn Injury | Phase 4 | Status: WITHDRAWN